Initial clinical results are promising, showing that regenerative therapies like MUSE Stemcell can reverse brain age by an average of 13.6 years and reproductive system age by 4.9 years, with lifestyle changes also improving overall biological age.

Generation Lab aims to transform healthcare from reactive to proactive by providing early diagnostic insights that facilitate targeted interventions to slow or reverse aging processes.

Generation Lab, a longevity startup co-founded by Dr. Irina Conboy, has secured $11 million in seed funding to expand its innovative diagnostic tool, SystemAge, which measures biological aging across multiple organ systems.

This funding round, led by Accel and including investors like Samsung Next and Zone2, brings the company's total funding to $15 million.

Since its launch last year, Generation Lab has rapidly grown, partnering with over 275 clinics worldwide and accumulating more than 300 million aging data points, demonstrating significant commercial momentum.

SystemAge evaluates the health and aging of 19 organ systems through a direct blood test, providing specific biological ages and risk profiles to enable targeted health interventions.

The company's approach emphasizes 'biological noise,' a measurable dysregulation in molecular systems that signals early decline or disease risk, offering a more precise and actionable aging diagnostic than traditional clocks.